Highland Capital Management (Texas)’s Acceleron Pharma XLRN Stock Holding History

Highland Capital Management (Texas)’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,000	Closed	-$291K	–	386
2018 Q2	$291K	Buy	+6,000	New	+$219K	0.02%	274
2016 Q3	–	Sell	-46,863	Closed	-$1.59M	–	380
2016 Q2	$1.59M	Buy	+46,863	New	+$1.52M	0.07%	169
2015 Q3	–	Sell	-53,500	Closed	-$1.69M	–	333
2015 Q2	$1.69M	Sell	53,500 -6,500	-11%	-$210K	0.03%	200
2015 Q1	$2.28M	Buy	60,000 +10,200	+20%	+$406K	0.05%	173
2014 Q4	$1.94M	Buy	+49,800	New	+$1.74M	0.06%	138

Other funds holding XLRN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Highland Capital Management (Texas)'s XLRN Position: Q3 2018 in Review

Highland Capital Management (Texas) sold out of Acceleron Pharma (XLRN) in Q3 2018, closing a stake of 6,000 shares — an estimated $291K sold.

Highland Capital Management (Texas) first reported a position in XLRN in Q4 2014 and held it in 5 quarters. The position peaked at $2.28M in Q1 2015. 167 funds tracked by Wall St. Rank hold XLRN as of Q3 2018.

Highland Capital Management (Texas) reported no remaining Acceleron Pharma position as of Q3 2018 after selling out during the quarter.
Highland Capital Management (Texas) sold 6,000 Acceleron Pharma shares in Q3 2018, an estimated $291K.
Highland Capital Management (Texas) first reported a position in Acceleron Pharma in Q4 2014 and held it in 5 quarters.
Highland Capital Management (Texas)'s Acceleron Pharma position peaked at $2.28M in Q1 2015.
167 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q3 2018, filed 14 Nov 2018.